[
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "<500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "10",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "1",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "100",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "500",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "<250",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "100",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "50",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "10",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "1",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "Immunoglobulin",
        "protein_target_name": "human ALK2",
        "binding_metric": "Kd",
        "value": "100",
        "unit": "pM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs used herein, the terms “specific binding,” “selective binding,” “selectively binds,” and “specifically binds,” refer to antibody binding to an epitope on a predetermined antigen but not to other antigens. Typically, the antibody (i) binds with an equilibrium dissociation constant (K<sub>D</sub>) of approximately less than 500 nM, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM or even lower when determined by, e.g., surface plasmon resonance (SPR) technology in a BIACORE® 2000 surface plasmon resonance instrument using the predetermined antigen, e.g., recombinant human ALK2, as the analyte and the antibody as the ligand, bio-layer interferometry, or Scatchard analysis of binding of the antibody to antigen positive cells, and (ii) binds to the predetermined antigen with an affinity that is at least two-fold greater than its affinity for binding to a non-specific antigen (e.g., BSA, casein) other than the predetermined antigen or a closely-related antigen.\nAccordingly, unless otherwise indicated, an antibody that “specifically binds to human ALK2” refers to an antibody that binds to soluble or cell bound human ALK2 with a K<sub>D </sub>of 500 nM or less, such as approximately less than 250 nM, 100 nM, 50 nM, 10 nM, 1 nM, or 100 pM, or even lower."
    },
    {
        "molecule_name": "JAB0481",
        "protein_target_name": "ALK2 ECD",
        "binding_metric": "Kd",
        "value": "155",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nThe dissociation constant (K<sub>D</sub>) determined for binding of JAB0481 to recombinant human ALK2 ECD was determined to be 155 nM when measured with the low density JAB0481 sensor and to be 72.7 nM when measured with the high density JAB0481 sensor.\nJAB0481LowACVR15.36 × 10<sup>4</sup>8.33 × 10<sup>−3</sup>1.55 × 10<sup>−7</sup>1.74ECD\nJAB0481HighACVR16.42 × 10<sup>4</sup>4.67 × 10<sup>−3</sup>7.27 × 10<sup>−8</sup>10.1ECD"
    },
    {
        "molecule_name": "JAB0481",
        "protein_target_name": "ALK2 ECD",
        "binding_metric": "Kd",
        "value": "72.7",
        "unit": "nM",
        "is_logarithmic": false,
        "raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\nThe dissociation constant (K<sub>D</sub>) determined for binding of JAB0481 to recombinant human ALK2 ECD was determined to be 155 nM when measured with the low density JAB0481 sensor and to be 72.7 nM when measured with the high density JAB0481 sensor.\nJAB0481LowACVR15.36 × 10<sup>4</sup>8.33 × 10<sup>−3</sup>1.55 × 10<sup>−7</sup>1.74ECD\nJAB0481HighACVR16.42 × 10<sup>4</sup>4.67 × 10<sup>−3</sup>7.27 × 10<sup>−8</sup>10.1ECD"
    }
]